Matches in Wikidata for { <http://www.wikidata.org/entity/Q66408188> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q66408188 description "clinical trial" @default.
- Q66408188 description "ensayu clínicu" @default.
- Q66408188 description "klinisch onderzoek" @default.
- Q66408188 description "клінічне випробування" @default.
- Q66408188 name "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" @default.
- Q66408188 name "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" @default.
- Q66408188 type Item @default.
- Q66408188 label "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" @default.
- Q66408188 label "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" @default.
- Q66408188 prefLabel "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" @default.
- Q66408188 prefLabel "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" @default.
- Q66408188 P1132 Q66408188-A7A48257-EEFB-45F7-89E0-5D14EF3DB7B1 @default.
- Q66408188 P1476 Q66408188-FD8F9627-12E8-41CF-BA7F-171D6CA9812E @default.
- Q66408188 P17 Q66408188-160F738C-5106-4492-B637-CEC00BB1B993 @default.
- Q66408188 P17 Q66408188-2B427EB5-E459-4B0E-945C-77FE48E29F16 @default.
- Q66408188 P17 Q66408188-7334A85E-6D4B-4A47-A8D5-6466F7554186 @default.
- Q66408188 P17 Q66408188-7E39B279-CDEF-4E88-BBA4-0239C603D17E @default.
- Q66408188 P17 Q66408188-A828E453-70BB-4F41-B67D-FE3CDBD8BB21 @default.
- Q66408188 P17 Q66408188-CC197E05-3620-4DED-85CE-F053F293E2CF @default.
- Q66408188 P17 Q66408188-D3696FA1-C948-451C-B3D0-EEC06A47C590 @default.
- Q66408188 P17 Q66408188-E0557501-4D7B-432E-BEDB-555790274B74 @default.
- Q66408188 P1813 Q66408188-B5228221-E684-41F1-9D3D-B3CAF0587B97 @default.
- Q66408188 P2283 Q66408188-8A793EAE-B54F-4244-9114-361CB9122207 @default.
- Q66408188 P2899 Q66408188-8BE4CAE2-1172-4D67-BF2B-52B819B69DBF @default.
- Q66408188 P3098 Q66408188-A5B4775A-F1BD-49A0-8EDB-297F17BA1BFC @default.
- Q66408188 P31 Q66408188-30DE63E8-DBD2-4F0C-8F6C-532E99708C35 @default.
- Q66408188 P4844 Q66408188-E1012CE8-6F96-4709-8579-A38C33D18BE8 @default.
- Q66408188 P580 Q66408188-FDE05E11-CA91-4B3E-B84E-3B25A5AE7889 @default.
- Q66408188 P582 Q66408188-345A93C3-7794-420B-97E7-12A21FADAF16 @default.
- Q66408188 P6099 Q66408188-6A0A0063-C0A6-4F0F-AF52-FC5FD59D3BA0 @default.
- Q66408188 P8363 Q66408188-01501997-A104-40F3-9ED4-2D5708C32604 @default.
- Q66408188 P1132 "+540" @default.
- Q66408188 P1476 "A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors" @default.
- Q66408188 P17 Q142 @default.
- Q66408188 P17 Q145 @default.
- Q66408188 P17 Q16 @default.
- Q66408188 P17 Q29 @default.
- Q66408188 P17 Q30 @default.
- Q66408188 P17 Q35 @default.
- Q66408188 P17 Q36 @default.
- Q66408188 P17 Q38 @default.
- Q66408188 P1813 "GARNET" @default.
- Q66408188 P2283 Q1755136 @default.
- Q66408188 P2899 "+18" @default.
- Q66408188 P3098 "NCT02715284" @default.
- Q66408188 P31 Q30612 @default.
- Q66408188 P4844 Q50429626 @default.
- Q66408188 P580 "2016-03-28T00:00:00Z" @default.
- Q66408188 P582 "2020-02-01T00:00:00Z" @default.
- Q66408188 P6099 Q5452194 @default.
- Q66408188 P8363 Q78089383 @default.